Email This Article

Headlines & Perspectives
Obesity Drug Arena's Heavy Burden
By Adam Feuerstein
03/23/09 - 01:19 AM EDT
Drug company Arena Pharmaceuticals is under pressure to produce stellar results from a phase III study of its obesity drug later this month.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,462.81 1,105.46 2,188.42 35.37
Oil *
71.71
UP
56.98
UP
3.11
DOWN
2.44
UP
0.55
10 Yr
3.54%
SPDR Gold
109.58
+0.55%
+0.28%
-0.11%
+1.58%
Data delayed 20 minutes

Brokerage Partners